LDL stands for low-density lipoprotein, a type of particle in your blood that carries cholesterol to cells throughout your body. It’s often called “bad cholesterol” because when levels get too high, LDL particles build up inside artery walls and increase the risk of heart attack and stroke. A standard blood test (lipid panel) measures how much cholesterol your LDL particles carry, reported in milligrams per deciliter (mg/dL).
What LDL Actually Does in Your Body
LDL particles are tiny spheres with a fatty core wrapped in a shell of phospholipids and a single protein called apoB. Their job is to shuttle cholesterol through the bloodstream and deliver it to cells that need it for building membranes and making repairs. This is a normal, necessary function. The problem starts when there are more LDL particles circulating than your cells can use.
Excess LDL particles slip through the inner lining of your arteries, especially at curves and branch points where blood flow is turbulent. Once trapped in the artery wall, they get chemically modified through oxidation. Your immune system treats these modified particles as invaders, sending white blood cells called monocytes to engulf them. Those monocytes transform into macrophages, gorge on the trapped LDL, and swell into what scientists call “foam cells.” Clusters of foam cells form fatty streaks, the earliest visible stage of plaque buildup. Over years, this process layers on more fat, inflammatory cells, and eventually calcium, narrowing the artery and making the plaque vulnerable to rupture.
This chain reaction is self-reinforcing. The inflammatory macrophages release signals that recruit even more immune cells, oxidize more LDL, and damage the artery lining further. The higher your LDL level, the more raw material feeds this cycle.
What Your LDL Number Means
Most adults get their LDL measured as part of a routine lipid panel. The number on your lab report reflects how much cholesterol mass is carried by your LDL particles, not how many particles you have (more on that distinction below). Here’s how to interpret the ranges:
- Below 100 mg/dL: the general target for adults at borderline or moderate cardiovascular risk.
- Below 70 mg/dL: the goal for people at high risk (a 10-year risk of cardiovascular disease of 10% or greater).
- 130 to 159 mg/dL: considered borderline high for most adults.
- 160 to 189 mg/dL: high.
- 190 mg/dL and above: classified as severe hypercholesterolemia, which often signals a genetic component and typically requires medication regardless of other risk factors.
For children and adolescents, the thresholds are lower: below 110 mg/dL is considered acceptable, 110 to 129 is borderline, and 130 or above is abnormal.
Your ideal target depends on your overall risk profile, not just the LDL number in isolation. Factors like age, blood pressure, diabetes, smoking status, and family history all shape which threshold applies to you. The 2026 guidelines from the American Heart Association and American College of Cardiology use a 10-year risk calculator to sort people into low, borderline, intermediate, and high-risk categories, each with different LDL goals.
LDL Cholesterol vs. LDL Particle Count
The standard test measures how much cholesterol your LDL particles carry in total. But individual LDL particles vary in size and cholesterol content by more than twofold from person to person. Someone with large, cholesterol-rich particles might have the same LDL cholesterol reading as someone with many small, cholesterol-poor particles, yet the second person has significantly more particles circulating and a higher cardiovascular risk.
Research from the Journal of Clinical Lipidology found that when LDL cholesterol and LDL particle count tell different stories, particle count is the better predictor. In people with mismatched readings, higher particle count was associated with a 45% increased risk of cardiovascular events, while the cholesterol concentration alone showed no meaningful association. This is why some doctors order an advanced lipid panel that reports particle number (LDL-P) or apoB concentration, particularly for patients whose standard numbers seem reassuring but who have other risk factors like insulin resistance or a family history of early heart disease.
How Standard LDL Tests Are Calculated
Most labs don’t measure your LDL directly. Instead, they measure total cholesterol, HDL cholesterol, and triglycerides, then calculate LDL using a formula developed in the 1970s called the Friedewald equation. This works well for most people, but the formula becomes unreliable when triglycerides are above 400 mg/dL or below 100 mg/dL, or when blood is drawn without fasting. In those situations, a direct LDL measurement is more accurate. If you’ve eaten within 8 to 12 hours of your blood draw and your triglycerides are elevated, your calculated LDL may be artificially low.
Lowering LDL Through Lifestyle Changes
Diet and weight management can meaningfully reduce LDL, though the effect varies by person. Losing 10 pounds typically lowers LDL by 5 to 8%. Adding 5 to 10 grams of soluble fiber per day (from sources like oats, beans, barley, or psyllium) can reduce it another 3 to 5%. Replacing saturated fats with unsaturated fats has a well-documented effect as well. Stacked together, these dietary shifts can produce a cumulative reduction that’s clinically significant for people starting at borderline levels.
Regular physical activity has a more modest direct effect on LDL, but it raises HDL, lowers triglycerides, and improves the cluster of metabolic problems (excess abdominal fat, high blood sugar, high blood pressure) that make LDL more dangerous. Exercise also tends to shift LDL particles toward larger, less harmful sizes.
When Medication Is Needed
For many people, lifestyle changes alone won’t bring LDL to goal, especially if genetics are a major driver. Statins remain the first-line treatment and reduce LDL by roughly 20 to 65% depending on the type and dose. They work by blocking an enzyme your liver uses to manufacture cholesterol, which forces liver cells to pull more LDL out of the bloodstream.
When statins aren’t enough or aren’t tolerated, other options exist. Adding a cholesterol absorption blocker can bring the total LDL reduction to around 45 to 50% compared to no treatment. Injectable medications that block a protein called PCSK9 (which normally prevents your liver from clearing LDL) achieve similar reductions of roughly 44 to 50% and are typically reserved for people at very high risk or those with genetic conditions. Newer injectable options given only twice a year are also available. For the highest-risk patients with LDL at or above 190 mg/dL who already have established cardiovascular disease, the current guidelines set an aggressive target of below 55 mg/dL, often requiring combination therapy.
Small Dense LDL and Why Particle Size Matters
Not all LDL particles pose equal risk. Smaller, denser particles are more likely to penetrate artery walls, more susceptible to oxidation once trapped, and less efficiently cleared by the liver. People with insulin resistance, type 2 diabetes, or high triglycerides tend to produce a greater proportion of these small dense particles. This partly explains why someone with a “normal” LDL cholesterol reading can still develop heart disease: their particle count may be high and their particles may be the more harmful type. Conditions that drive small dense LDL, like metabolic syndrome, respond well to weight loss, reduced refined carbohydrate intake, and regular exercise.